Retraction Note : Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer
| Errataetall: |
RetractionOf: Oncogene. 2009 Mar 5;28(9):1248-60. - PMID 19151763 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Oncogene - 41(2022), 24 vom: 19. Juni, Seite 3383 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khandrika, Lakshmipathi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.06.2022 Date Revised 10.08.2023 published: Print RetractionOf: Oncogene. 2009 Mar 5;28(9):1248-60. - PMID 19151763 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41388-022-02357-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34112687X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34112687X | ||
| 003 | DE-627 | ||
| 005 | 20231226011049.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41388-022-02357-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1137.xml |
| 035 | |a (DE-627)NLM34112687X | ||
| 035 | |a (NLM)35589952 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khandrika, Lakshmipathi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retraction Note |b Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.06.2022 | ||
| 500 | |a Date Revised 10.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a RetractionOf: Oncogene. 2009 Mar 5;28(9):1248-60. - PMID 19151763 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Retraction of Publication | |
| 700 | 1 | |a Lieberman, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Koul, Sweaty |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Binod |e verfasserin |4 aut | |
| 700 | 1 | |a Maroni, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Chandhoke, Ryan |e verfasserin |4 aut | |
| 700 | 1 | |a Meacham, Randall B |e verfasserin |4 aut | |
| 700 | 1 | |a Koul, Hari K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncogene |d 1990 |g 41(2022), 24 vom: 19. Juni, Seite 3383 |w (DE-627)NLM012595683 |x 1476-5594 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2022 |g number:24 |g day:19 |g month:06 |g pages:3383 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41388-022-02357-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2022 |e 24 |b 19 |c 06 |h 3383 | ||